Marksans Pharma Limited (NSE: MARKSANS)
India
· Delayed Price · Currency is INR
283.10
+10.05 (3.69%)
Oct 8, 2024, 3:26 PM IST
Marksans Pharma Revenue
Marksans Pharma had revenue of 5.91B INR in the quarter ending June 30, 2024, with 18.12% growth. This brings the company's revenue in the last twelve months to 22.68B, up 18.22% year-over-year. In the fiscal year ending March 31, 2024, Marksans Pharma had annual revenue of 21.77B with 17.56% growth.
Revenue (ttm)
22.68B
Revenue Growth
+18.22%
P/S Ratio
5.74
Revenue / Employee
19.88M
Employees
1,141
Market Cap
129.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 21.77B | 3.25B | 17.56% |
Mar 31, 2023 | 18.52B | 3.61B | 24.23% |
Mar 31, 2022 | 14.91B | 1.15B | 8.33% |
Mar 31, 2021 | 13.76B | 2.42B | 21.32% |
Mar 31, 2020 | 11.34B | 1.34B | 13.43% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition